Repligen Corp Second Quarter Earnings Sneak Peek

Repligen Corporation (NASDAQ:RGEN) will unveil its latest earnings on Friday, October 28, 2011. Repligen is a biopharmaceutical company focused primarily on the development of novel therapeutics for radiology and neuropsychiatry.

Repligen Corporation Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for a loss of 2 cents per share, a swing from net income of 2 cents in the year earlier quarter. During the past three months, the average estimate has moved down from breaking even. Between one and three months ago, the average estimate moved down. It has been unchanged at a loss of 2 cents during the last month.

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.

Wall St. Revenue Expectations: Analysts are projecting a rise of 2.6% in revenue from the year-earlier quarter to $7.5 million.

A Look Back: In the first quarter, the company swung to a loss of $55,597 (0 cents a share) from a profit of $988,053 (3 cents) a year earlier, meeting analyst expectations. Revenue rose 9.2% to $7.7 million from $7 million.

Key Stats:

Revenue has risen the past four quarters. Revenue rose 21.2% in the fourth quarter of the last fiscal year from the year earlier, climbed 25.8% in the third quarter of the last fiscal year from the year-ago quarter and 34.8% in the second quarter of the last fiscal year.

Competitors to Watch: Life Technologies Corp. (NASDAQ:LIFE), Bristol Myers Squibb Co. (NYSE:BMY), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), EntreMed, Inc. (NASDAQ:ENMD), Titan Pharmaceuticals, Inc. (TTNP), Amgen, Inc. (NASDAQ:AMGN), Neuralstem, Inc. (AMEX:CUR), General Electric Company (NYSE:GE), Novavax, Inc. (NASDAQ:NVAX), and Sangamo Biosciences, Inc. (NASDAQ:SGMO).

Stock Price Performance: During August 1, 2011 to October 25, 2011, the stock price had fallen 27 cents (-7.8%) from $3.48 to $3.21. The stock price saw one of its best stretches over the last year between December 17, 2010 and December 28, 2010 when shares rose for seven-straight days, rising 20.3% (+80 cents) over that span. It saw one of its worst periods between July 26, 2011 and August 3, 2011 when shares fell for seven-straight days, falling 9.3% (-35 cents) over that span. Shares are down $1.48 (-31.6%) year to date.

(Source: Xignite Financials)

Investing Insights: Here’s Why Chipotle’s Stock Keeps Winning.